Cardio Diagnostics Holdings, Inc. (CDIO)
1.925
-0.10
(-5.17%)
USD |
NASDAQ |
Aug 24, 16:00
1.97
+0.04
(+2.34%)
After-Hours: 20:00
Cardio Diagnostics Holdings Gross Profit Margin (Quarterly) : -824.1% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -824.1% |
| March 31, 2026 | -3.41K% |
| December 31, 2025 | -4.33K% |
| September 30, 2025 | -2.99K% |
| June 30, 2025 | -1.09K% |
| March 31, 2025 | -13.82K% |
| December 31, 2024 | -1.78K% |
| Date | Value |
|---|---|
| September 30, 2024 | -1.15K% |
| June 30, 2024 | -416.5% |
| March 31, 2024 | 47.17% |
| December 31, 2023 | -1.71K% |
| September 30, 2023 | 39.00% |
| June 30, 2023 | -182.4% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -- |
| Exicure, Inc. | -- |
| Century Therapeutics, Inc. | -- |
| Absci Corp. | -747.8% |
| Celularity, Inc. | -123.6% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -78.55% |
| Return on Assets | -63.18% |
| Return on Invested Capital | -73.71% |
| Profit Margin (Quarterly) | -27.81K% |
| Operating Margin (Quarterly) | -27.74K% |
| Return on Net Operating Assets | -361.1% |